Use of G-CSF to Sustain Dose Intensity in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Pilot Study
Author:
Affiliation:
1. H. Lee Moffitt Cancer Center & Research Insitute at the University of South Florida, Tampa, FL
2. Albert-Ludwigs Universitüt, Freiburg, Germany
Abstract
Publisher
SAGE Publications
Subject
Oncology,Hematology,General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/107327489600300605
Reference12 articles.
1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
2. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.
3. A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.
4. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.
5. Decision Analysis of Hematopoietic Growth Factor Use in Patients Receiving Cancer Chemotherapy
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Granulocyte Colony-Stimulating Factor Utilization and Prescribing Patterns in Cancer Patients: A Single Institution Experience of a Saudi Cancer Center;Cureus;2022-07-19
2. Advances in the pharmacological management of neutropenia in solid tumors: the advent of biosimilars;Expert Opinion on Pharmacotherapy;2021-02-12
3. Efficacy and Safety of Lipegfilgrastim in Lung Cancer Patients Receiving Myelosuppressive Chemotherapy in a Real-World Setting: Results of an Analysis of Pooled Data from Two Non-Interventional European Studies;Oncology Research and Treatment;2021-01-21
4. Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events;Journal of Oncology Pharmacy Practice;2017-06-14
5. Temporal and Geographic Variations in the Receipt of Colony-Stimulating Factors and Erythropoiesis-Stimulating Agents in a Large Retrospective Cohort of Older Women With Breast Cancer From 2000 to 2009;American Journal of Therapeutics;2016-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3